What is the medical indication for Gravol (dimenhydrinate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Indications for Dimenhydrinate (Gravol)

Dimenhydrinate is primarily indicated for the prevention and treatment of nausea, vomiting, or vertigo associated with motion sickness. 1

Primary Indications

Dimenhydrinate is an H1-receptor antagonist with antiemetic properties that has several established medical uses:

  1. Motion Sickness

    • Prevention and treatment of nausea, vomiting, and vertigo associated with motion sickness 1
    • Effective in reducing symptoms by suppressing abnormal gastric myoelectric activity and depressing central nervous system activity 2
  2. Nausea and Vomiting in Various Contexts

    • Acute nausea and vomiting from various causes
    • Postoperative nausea and vomiting (PONV) - comparable efficacy to ondansetron but at significantly lower cost 3
    • Pregnancy-related nausea and vomiting when first-line non-pharmacologic approaches fail 4
  3. Vertigo

    • Management of vertigo symptoms in conditions like Ménière's disease 4

Dosing and Administration

  • Adults: 25-50 mg orally, 3-4 times daily
  • Children: Dosing based on weight and age (pediatric use should be carefully considered) 5
  • Available forms: Oral tablets, liquid, injectable formulations, and suppositories

Clinical Applications in Specific Conditions

Pregnancy-Related Nausea and Vomiting

Dimenhydrinate is considered a safe first-line pharmacologic antiemetic therapy for persistent nausea and vomiting of pregnancy (NVP) that is refractory to non-pharmacologic therapy such as ginger and vitamin B6 (pyridoxine) 4. The American College of Obstetricians and Gynecologists (ACOG) recognizes it as an appropriate option when non-pharmacologic approaches fail.

Gastroparesis

In refractory gastroparesis, dimenhydrinate (25-50 mg three times daily) may be used as an antiemetic option for symptom management 4. However, it is not a first-line therapy for this condition.

Infectious Diarrhea

For patients with infectious diarrhea accompanied by nausea and vomiting, antiemetic agents including dimenhydrinate may be considered once the patient is adequately hydrated 4. However, fluid and electrolyte therapy should remain the primary treatment.

Ménière's Disease

Dimenhydrinate may be used to reduce symptoms of vertigo in patients with Ménière's disease 4.

Important Precautions and Limitations

  • Not for primary antiemetic use: Dimenhydrinate is not recommended as a primary antiemetic agent in chemotherapy-induced nausea and vomiting, where 5-HT3 antagonists are preferred 6

  • Side effects: Common side effects include drowsiness, dry mouth, blurred vision, and potential for anticholinergic effects, particularly in elderly patients 6

  • Risk of abuse: There is potential for abuse due to anticholinergic properties that can produce euphoria, anxiolysis, and hallucinations at supratherapeutic doses 7

  • Contraindications: Use with caution in patients with glaucoma, prostatic hypertrophy, asthma, or bladder neck obstruction

Conclusion

Dimenhydrinate is a versatile antiemetic medication primarily indicated for motion sickness but with applications in various other conditions causing nausea, vomiting, or vertigo. While effective for these indications, it should be used judiciously, especially in pediatric and elderly populations, and with awareness of its potential side effects and abuse potential.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dimenhydrinate use for children with vomiting.

Canadian family physician Medecin de famille canadien, 2011

Guideline

Antiemetic Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.